Elahere

Elahere Warnings and Precautions

• Elahere may cause serious eye problems, including blurred vision, dry eyes, light sensitivity, and corneal changes. Use prescribed eye drops, attend regular eye exams, report vision changes immediately, and avoid contact lenses unless advised by your doctor.
• Treatment with mirvetuximab soravtansine-gynx may cause serious or life-threatening lung inflammation. Contact your healthcare provider immediately if you develop a new or worsening cough, shortness of breath, or chest discomfort. Treatment may be delayed or permanently stopped if severe pneumonitis occurs.
• This therapeutic drug may cause nerve damage, leading to numbness, tingling, burning, pain, or weakness in your hands and feet. Report these symptoms promptly, as your doctor may adjust the dose or temporarily stop treatment.
• Infusion-related reactions, including fever, chills, flushing, breathing difficulty, or low blood pressure, may occur during treatment. You will be monitored closely, and the infusion may be slowed, paused, or stopped if needed.
• This medicine may harm an unborn baby. Use effective contraception during treatment and for the recommended period afterward. Do not breastfeed during treatment or until your doctor advises it is safe after the last dose.
• Elahere therapy may cause blurred vision, tiredness, or reduced alertness. Avoid driving, operating machinery, or performing activities requiring clear vision until your doctor confirms it is safe to do so.
• This medicinal product may increase liver enzymes and reduce blood counts, albumin, or magnesium levels. Your healthcare provider will perform blood tests before each treatment to monitor your health and manage any side effects early.

How to Access Elahere in India: A 6-Step Process

• Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.
• Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements — including confirmation of FRα-positive status and prior treatment history — to ensure a compliant pathway.
  

Documentation & Availability

What documents are required to import ELAHERE to India?

• A valid prescription from a qualified doctor
• The patient's diagnostic reports, including the FRα (folate receptor alpha) test report confirming eligibility and documentation of prior lines of therapy
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

Is ELAHERE available in India?

• Availability of Elahere in India and pathways to access it
• Availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE)
• Elahere price in India under the NPP route
• Sourcing from genuine, reliable channels in the USA, Europe, China, Singapore, Canada, and Australia
• Ensuring full transparency throughout the process

Sourcing & Delivery of Elahere

Availability of Elahere Across Major Cities in India

Patients across India can access Elahere® through regulated import pathways, with delivery arranged to the treating hospital based on a valid oncologist's prescription.

Mumbai: A major gynaecologic oncology hub with institutions like Tata Memorial, Mumbai, sees high demand for biomarker-directed therapies like Elahere®. Access is often coordinated for patients undergoing specialised ovarian cancer care.

Bangalore: With a growing network of multispecialty hospitals and molecular pathology laboratories capable of FRα testing, Bangalore supports access to global oncology treatments through structured import pathways guided by treating specialists.

Delhi: As part of the Delhi NCR region, the city has a strong concentration of cancer centers and gynaecologic oncology specialists, making it a key location for accessing advanced imported therapies.

Gurgaon: Home to leading hospitals like Medanta, Gurgaon plays an important role in facilitating access to innovative cancer treatments through coordinated care pathways.

Noida: With proximity to Delhi and access to top hospitals, Noida patients benefit from streamlined logistics and specialist-driven treatment planning.

Hyderabad: Hyderabad's advanced healthcare infrastructure and oncology expertise support patients seeking access to internationally approved cancer therapies.

Chennai: Known for its established medical ecosystem, Chennai attracts patients from across India for complex cancer treatments and specialized drug access.

Kolkata: A key eastern healthcare hub, Kolkata offers access to advanced oncology care through leading hospitals and treatment centers.

Ahmedabad: Ahmedabad's expanding healthcare sector and oncology facilities support patients requiring advanced and imported cancer therapies.

Pune: With reputed hospitals and a growing cancer care infrastructure, Pune is an emerging center for access to specialized oncology treatments.

Chandigarh: Serving North India, Chandigarh provides access to advanced medical care through reputed institutions and specialist-led treatment planning.

Jaipur: Jaipur's improving healthcare network enables patients to explore access to innovative cancer therapies through structured import processes.

Lucknow: As a major city in North India, Lucknow supports access to advanced oncology treatments through both public and private healthcare institutions.

Indore: Indore is emerging as a regional healthcare hub, offering access to specialized cancer care and modern treatment pathways.

Bhopal: Patients in Bhopal can access advanced cancer treatments through the growing healthcare infrastructure and referral networks.

Nagpur: Nagpur serves as a central hub for patients across Vidarbha, with increasing access to oncology care and specialized therapies.

Surat: Surat's developing healthcare ecosystem supports patients seeking access to global oncology treatments through coordinated care.

Patna: As a major city in Eastern India, Patna provides growing access to cancer treatment through expanding hospital networks.

Coimbatore: Coimbatore is known for quality healthcare services, offering access to advanced oncology treatments in South India.

Kochi: With modern hospitals and specialist care, Kochi enables patients to explore access to internationally approved cancer therapies.

Note: Access timelines may vary depending on documentation, regulatory approvals, and sourcing logistics.

Access/Buy Elahere® at Leading Hospitals in India

Elahere® is administered in advanced gynaecologic-oncology settings with day-care infusion facilities and access to ophthalmology support, and can be accessed at leading hospitals across India, where specialists guide treatment decisions and coordinate patient-specific access pathways.

Major Hospitals Covered:

Tata Memorial Centre: One of India's premier cancer institutes, Tata Memorial plays a key role in managing complex ovarian cancer cases and guiding patients toward advanced therapies like Elahere®.

AIIMS: As a leading government medical institution, AIIMS provides comprehensive cancer care and supports patients requiring access to specialized and emerging treatments.

Apollo Hospitals: With a nationwide presence, Apollo Hospitals offers advanced oncology services and facilitates access to global treatment options through its extensive medical network.

Fortis Healthcare: Fortis hospitals are equipped with modern cancer care facilities and multidisciplinary teams that manage complex treatment pathways for patients.

Max Healthcare: Max Healthcare is known for its strong medical and gynaecologic oncology departments, providing access to innovative therapies under expert clinical supervision.

Manipal Hospitals: Manipal Hospitals supports advanced cancer care through experienced specialists and structured treatment planning across multiple cities.

Kokilaben Dhirubhai Ambani Hospital: A leading private hospital in Mumbai, Kokilaben Hospital offers cutting-edge oncology care and access to advanced global therapies.

Medanta – The Medicity: Medanta is a renowned super-specialty hospital where complex cancer cases are managed with advanced treatment protocols and global access support.

BLK-Max Super Speciality Hospital: BLK-Max provides comprehensive oncology services and supports patients seeking access to specialized treatment options.

Rajiv Gandhi Cancer Institute: A dedicated cancer care center, RGCI focuses on advanced oncology treatments and supports patients through complex treatment journeys.

HCG Cancer Centre: HCG is a specialized cancer hospital network known for its focus on precision oncology and advanced treatment modalities.

Narayana Health: Narayana Health combines affordability with advanced medical care, offering oncology services across multiple locations in India.

Amrita Hospital: Amrita Hospital provides high-quality cancer care with a focus on patient-centric treatment and access to modern therapies.

Yashoda Hospitals: Yashoda Hospitals are known for their strong oncology departments and advanced treatment infrastructure in South India.

Aster Hospitals: Aster Hospitals offer integrated cancer care services and support access to innovative therapies through coordinated treatment planning.

Sir Ganga Ram Hospital: A well-established hospital in Delhi, Sir Ganga Ram provides multidisciplinary cancer care supported by experienced specialists.

Jaslok Hospital: Jaslok Hospital is known for its specialized medical services and advanced oncology treatment capabilities.

Ruby Hall Clinic: Ruby Hall Clinic offers comprehensive cancer care and supports patients requiring advanced and imported therapies.

CARE Hospitals: CARE Hospitals provide modern oncology treatment facilities and multidisciplinary care across multiple cities.

Global Hospitals: Global Hospitals are equipped with advanced medical technologies and oncology expertise to manage complex cancer cases.

Note: Elahere® is not stocked for direct purchase but is arranged through compliant import processes and delivered to the hospital for patient-specific treatment.